Our Dual Lens Approach

BVGH works to solve major global health problems by finding the common ground between the needs of patients in poor countries and the pragmatic needs of companies.

Image
 
Image
  
  

Revised formula yields a lower priority review voucher user fee of $3,559,000; will that help spark greater interest in the program?

09/20/2012
The FDA law blog analyzes a change in FDA policy for FY2013. On September 13th, FDA announced that the user fee rate will be just $3,559,000 for redeeming a tropical disease priority review voucher in FY 2013. Read more
print